Trib Total Media
newspapers web sites magazines your town classifieds partners advertise help
 
 Hemispherx Biopharma Inc - HEB (AMEX)   1.02    -0.01  -0.97%   PRINT THIS
  EMAIL THIS
Overview News Releases Company Profile
Quote
Last Traded: 11/20/09 16:01 ET
Last 1.02
Change   -0.01
% Change -0.97%
Open 1.01
Bid 1.00
Bid Size 700
Ask 1.00
Ask Size 8,500
Day High 1.03
Day Low 0.9801
52 Week High 4.54
52 Week Low 0.26
Volume 1,092,078
Prev. Close 1.03
Tick Type EVEN
Last Trade Shr. 9,800
Industry: HEALTHCARE - DRUGS
 
Add HEB To :
  >> My Portfolio
  >> My Watchlist
  >> My StockAlerts
  >> message
  
Date Range:  Intraday | 5_Days | 15_Days | 1_Month | 3_Months | 1_Year | 2_Years | 3_Years
News Releases
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc.
11/20/2009 6:01 PM - GlobeNewswire
Class Action Lawsuit Against Hemispherx Biopharma is Without Merit
11/16/2009 8:45 AM - GlobeNewswire
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Hemispherx Biopharma, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the January 11, 2010 Lead Plaintiff
11/14/2009 9:12 AM - Marketwire
RothmanResearch.com Completes Analysis on TWX, LUV, HEB, HD, MDU and IR
11/13/2009 6:49 AM - Marketwire
Izard Nobel LLP Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc.
11/12/2009 4:38 PM - Marketwire

>> More HEB News Releases
Company Profile

A biopharmaceutical company, which is engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

>> More HEB Profile Information


HEMISPHERX BIOPHARMA INC
1617 JFK Boulevard
Suite 660
Philadelphia, PA US
19103

Website: http://www.hemispherx.net
Email: ir@hemispherx.net

Officers: Dr. William A. Carter, M.D., CEO


Fundamental Data
P/E Ratio
Earnings/Share-0.13
Dividend/Share0
Cur Div Yield0.0
Ex Div Date
Market Cap (Mil)135.38
Share Out (mil)132.72
 
Recommendations
No Recommendations.
Financial Highlights (All data for latest 12 months) Values in
Sales 0.10 Mil   Revenue/Share 0.00
Income -12.23 Mil   Earnings/Share -0.13
Net Profit Margin -   Book Value/Share 0.50
Return on Equity -   Dividend Rate 0.00
Debt/Equity Ratio -   Payout Ratio< 0.00%
 
Revenue - Quarterly Results (in millions)
  9/2009 9/2008 9/2007
 1st Qtr 0.0 0.3 0.2
 2nd Qtr 0.0 0.2 0.3
 3rd Qtr 0.0 0.0 0.2
 4th Qtr 0.0 0.0 0.3
 Total 0.1 0.5 1.0
 
Earnings Per Share - Quarterly Results
  9/2009 9/2008 9/2007
 1st Qtr ($0.03) ($0.04) ($0.07)
 2nd Qtr ($0.04) ($0.04) ($0.07)
 3rd Qtr ($0.04) ($0.04) ($0.05)
 4th Qtr ($0.02) ($0.05) ($0.08)
 Total ($0.13) ($0.17) ($0.27)
My Last 5 Quotes
PRK $61 $0.45
HPQ $50.04 $0.22
TGB $3.2 -$0.12
PEET $38 -$0.22
IVOI $0.0002 0.
Market Indexes
DOW 10318.16 EVEN
NASD 2146.04 EVEN
NYSE 7084.47 EVEN
S&P 500 1091.38 EVEN
TSX 11579.33 EVEN
TSX-V 1408.06 EVEN
Russell 584.68 EVEN
AMEX 1782.07 EVEN



 Watchlist Edit
No watchlist stocks
 

Quotes delayed at least 20 minutes for NYSE/AMEX, 15 minutes for other exchanges.
© 2009 Stockgroup. Terms & Conditions. Privacy Policy.  Corporate and Financial data provided by Morningstar.


Subscribe to the Tribune-Review today



Advertising Information | Advertiser List